FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Rising Pharma Holding Pregabalin Capsules 50mg Recall

Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma H…

Rising Pharma Holding, Inc. · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Jun 12, 2024
Recall ID
D-0541-2024
Check your lot numberHow we source this data

Summary

Rising Pharma Holding recalled Pregabalin Capsules 50mg starting May 16, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0541-2024 on Jun 12, 2024. Reason: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg. Status: Ongoing.

Why it was recalled

Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.

Product description

Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10

Lot numbers, UPCs & expiration codes

Lot: 23132611, Exp 07/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0541-2024
Classification
Class III
Status
Ongoing
Recall initiated
May 16, 2024
FDA report date
Jun 12, 2024
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Rising Pharma Holding, Inc.

Original FDA data

Every field from FDA enforcement report D-0541-2024, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
94642
Address
2 Tower Center Blvd Ste 1401
Code information
Lot: 23132611, Exp 07/31/2026
Postal code
08816-1149
Report date
Jun 12, 2024
Product type
Drugs
Recall number
D-0541-2024
Classification
Class III
Recalling firm
Rising Pharma Holding, Inc.
Reason for recall
Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10
Distribution pattern
Nationwide in the USA
Recall initiation date
May 16, 2024
Center classification date
Jun 4, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0541-2024, published Jun 12, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls